Hypopituitarism and mortality in pituitary adenoma
- 25 May 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (1), 51-58
- https://doi.org/10.1111/j.1365-2265.2006.02545.x
Abstract
Background and objective Previous studies on hypopituitarism and mortality have concluded that insufficient pituitary function is associated with decreased survival. For several reasons the results are difficult to compare – particularly because definitions and treatment of hypopituitarism have varied and various underlying disorders have been included. The purpose was to assess the relationship between mortality and pituitary function. Patients and design One hundred and sixty consecutive patients (99 men and 61 women) with functionless, suprasellar pituitary adenoma. All were operated on transsphenoidally during the period 1985–1996. Additional radiotherapy was given to 29 patients. Mortality was calculated 12·4 years (median, range 8·1–19·9) after operation. Postoperative hormonal deficits were treated in most, though GH substitution was given only to a minority of patients. Results Postoperatively 30% of the patients had normal pituitary function (normal adrenocortical, thyroid and gonadal function), 26% were panhypopituitary and 36% had partial pituitary insufficiency. Forty‐one patients had died (34·7 expected) yielding a standard mortality ratio (SMR) of 1·18 (95% confidence limits (CI) 0·87–1·60). SMR was significantly increased in women (1·97, CI 1·20–3·21) but not in men (0·83, CI 0·55–1·26). SMR in patients with normal pituitary function, panhypopituitarism and partial insufficiency were not different from that in the general population. SMR in hypopituitary women was substantially higher than in men with pituitary insufficiency. Treatment with growth hormone in GH‐deficient patients did not influence survival. Conclusion Pituitary surgery for nonfunctioning adenoma and subsequent pituitary insufficiency had no effect on mortality in men, but was associated with significantly increased mortality in women. Suboptimal hormonal substitution in women may play a role.Keywords
This publication has 32 references indexed in Scilit:
- Frequent occurrence of pituitary apoplexy in patients with non‐functioning pituitary adenomaClinical Endocrinology, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Diagnosis of GH Deficiency in Adults--How Good Do the Criteria Need to Be?Journal of Clinical Endocrinology & Metabolism, 2002
- Diagnosis of Growth Hormone (GH) Deficiency in Adults with Hypothalamic-Pituitary Disorders: Comparison of Test Results Using Pyridostigmine Plus GH-Releasing Hormone (GHRH), Clonidine Plus GHRH, and Insulin-Induced Hypoglycemia as GH SecretagoguesJournal of Clinical Endocrinology & Metabolism, 2000
- Increased cerebrovascular mortality in patients with hypopituitarismClinical Endocrinology, 1997
- The effect of hypopituitarism on life expectancyJournal of Clinical Endocrinology & Metabolism, 1996
- Cardiovascular function and glucocorticoid replacement in patients with hypopituitarismClinical Endocrinology, 1995
- Bemerkungen zur Operation der Hypophysengeschwülste1)Deutsche Medizinische Wochenschrift (1946), 1927
- Ueber Hypophysisschwund mit tödlichem Ausgang1)Deutsche Medizinische Wochenschrift (1946), 1914
- Über die Funktion der HypophysePflügers Archiv - European Journal of Physiology, 1912